Verdalia Bioenergy, a leading European biomethane company backed by Goldman Sachs Alternatives and industry leaders Fernando Bergasa and Cristina Ávila, has acquired a portfolio of greenfield biomethane plants in Italy. The plants were previously owned by Green Arrow Capital, an Italian alternative investment firm, and Lazzari & Lucchini, an energy development company.
The acquired portfolio includes five biomethane plants in the Lombardy and Veneto regions of Italy. These plants are in the late stages of development and are set to have a combined production capacity of 170 GWh of biomethane. The plants will process over 250,000 tonnes of raw materials annually, contributing to Italy’s growing renewable energy sector.
Construction is slated to begin shortly for four of the five plants, which are already eligible for the DM 2022 incentive scheme. The facilities are expected to be operational by the end of 2025 and will produce biomethane exclusively from animal residues and agricultural by-products not suitable for human consumption.
This strategic acquisition aligns with Verdalia’s sustainability goals, with the portfolio expected to reduce greenhouse gas emissions by approximately 50,000 tonnes annually. The acquisition follows Verdalia’s recent purchase of seven operating plants and four additional greenfield projects in northern Italy, further expanding the company’s presence in the renewable energy market.
By integrating these new projects, Verdalia Bioenergy is positioned to play a key role in Italy’s transition to cleaner, more sustainable energy sources, contributing to the country’s renewable energy targets and climate commitments.
